Año: 2021
Journal Impact Factor (JIF): 17.8730
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| PHARMACOLOGY & PHARMACY | SCIE | 4/279 | Q1 | T1 | D1 |
Año: 2021
Journal Citation Indicator (JCI): 2,330
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| PHARMACOLOGY & PHARMACY | 7/361 | Q1 | T1 | D1 | 98,20 |
Año:
2021
CiteScore:
22,300
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmaceutical Science | 1/171 | Q1 | T1 | D1 |
SJR año:
2021
Factor de Impacto:
2,934
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Pharmaceutical Science | 2/198 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| COST (European Cooperation in Science and Technology) - Horizon 2020 Framework Programme of the European Union | CA16205 |
| Czech Science Foundation | 18-00132S |
| Ministry of Education, Youth and Sports of the Czech Republic | LTC19039; LTC18003 |
| Polish National Centre for Research and Development | POIR.01.02.00-00-0011/17 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Vinarov, Zahari | KU Leuven; Sofia University St. Kliment Ohridski (Bulgaria) |
| 2 | Abrahamsson, Bertil | AstraZeneca Sweden (Sweden) |
| 3 | Artursson, Per | Uppsala Universitet (Sweden) |
| 4 | Batchelor, Hannah | University of Strathclyde (United Kingdom) |
| 5 | Berben, Philippe | UCB S.A. (Belgium) |
| 6 | Bernkop-Schnürch, Andreas | University of Innsbruck (Austria) |
| 7 | Butler, James | GlaxoSmithKline plc. (United Kingdom) |
| 8 | Ceulemans, Jens | Janssen Pharmaceutica, Headquarters (Belgium) |
| 9 | Davies, Nigel | AstraZeneca Sweden (Sweden) |
| 10 | Dupont, Didier | Science et Technologie du Lait et de l'Oeuf (STLO) (France) |
| 11 | Flaten, Gøril Eide | UiT The Arctic University of Norway (Norway) |
| 12 | Fotaki, Nikoletta | University of Bath (United Kingdom) |
| 13 | Griffin, Brendan T. | University College Cork (Ireland) |
| 14 | Jannin, Vincent | Lonza Pharma & Biotech (France) |
| 15 | Keemink, Janneke | Janssen Pharmaceutica, Headquarters (Belgium) |
| 16 | Kesisoglou, Filippos | Merck & Co., Inc. (United States) |
| 17 | Koziolek, Mirko | AbbVie (United States) |
| 18 | Kuentz, Martin | Fachhochschule Nordwestschweiz FHNW (Switzerland) |
| 19 | Mackie, Alan | University of Leeds (United Kingdom) |
| 20 | Meléndez-Martínez, Antonio J. | Universidad de Sevilla (Spain) |
| 21 | McAllister, Mark | Pfizer Limited, UK (United Kingdom) |
| 22 | Müllertz, Anette | Københavns Universitet (Denmark) |
| 23 | O'Driscoll, Caitriona M. | University College Cork (Ireland) |
| 24 | Parrott, Neil | F. Hoffmann-La Roche AG (Switzerland) |
| 25 | Paszkowska, Jadwiga | Physiolution Polska Sp. Z o.o. (Poland) |
| 26 | Pavek, Petr | Charles University (Czech Republic) |
| 27 | Porter, Christopher J.H. | Monash Institute of Pharmaceutical Sciences (Australia) |
| 28 | Reppas, Christos | National and Kapodistrian University of Athens (Greece) |
| 29 | Stillhart, Cordula | F. Hoffmann-La Roche AG (Switzerland) |
| 30 | Sugano, Kiyohiko | Ritsumeikan University Biwako-Kusatsu Campus (Japan) |
| 31 | Toader, Elena | Universitatea de Medicina si Farmacie Grigore T. Popa din Iasi (Romania) |
| 32 | Valentová, Kateřina | Academy of Sciences of the Czech Republic (Czech Republic) |
| 33 | Vertzoni, Maria | National and Kapodistrian University of Athens (Greece) |
| 34 | De Wildt, Saskia N. | Radboud University Nijmegen Medical Centre (Netherlands) |
| 35 | Wilson, Clive G. | University of Strathclyde (United Kingdom) |
| 36 | KU Leuven (Belgium) |
